
Leviroz 750mg Tablet
Marketer
Hauz Pharma Pvt Ltd
Salt Composition
Levetiracetam (750mg)
Overview Leviroz 750mg Tablet
Epileptic seizures are managed by the anticonvulsant Levetiracetam 750mg tablets. This medication, administered alone or in conjunction with other treatments, controls seizures by suppressing aberrant brain electrical activity. Consistent daily dosing, ideally at the same time, maximizes effectiveness. Dosage is individualized based on patient response and condition; your physician will determine the appropriate regimen. Long-term use is generally recommended; discontinuation or missed doses can exacerbate seizures, so continued use as directed is crucial, even during periods of wellness. Common side effects, often diminishing after the initial weeks, may include drowsiness, headaches, irritability, altered behavior (including aggression), and reduced appetite. While most are mild and don't require intervention, serious effects are possible; suicidal ideation has been reported in a small percentage of patients. Report any worsening mood immediately. Prior to commencing treatment, inform your doctor of any pre-existing kidney disease, depression, suicidal tendencies, or pregnancy/breastfeeding plans. Regular blood tests to monitor kidney function may be recommended.
Uses of Leviroz 750mg Tablet
Managing Epileptic Seizures
Major Benefits of Leviroz 750mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the 750mg Leviroz tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, however, consistent timing is recommended.
Common Side effects of Leviroz 750mg Tablet:
- Sleepiness
- Dizziness
- Fatigue
- Headache
- Decreased appetite
- Behavioral changes
- Aggressive behavior
- Irritation
- Agitation
- Nasal congestion (stuffy nose)
- Infection
- Convulsion
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Nausea
- Tremors
- Vertigo
- Lethargy
How to use Leviroz 750mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 750mg Leviroz tablet whole; do not damage it by chewing, crushing, or breaking. While it can be taken with or without food, consistent timing is recommended.
How Leviroz 750mg Tablet works:
Epileptic seizures are countered by Leviroz 750mg Tablets, an anticonvulsant. Its mechanism involves binding to neuronal SV2A receptors, thereby inhibiting excessive neuronal firing and preventing the propagation of seizure-inducing electrical impulses within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Leviroz 750mg Tablets is contraindicated.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Leviroz 750mg tablets is considered safe. Research indicates minimal to no fetal risk.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Leviroz 750mg tablets safely. Available human data indicates minimal infant risk. Observe the infant for drowsiness and appropriate weight increase.
DrivingUNSAFE
Taking a 750mg Leviroz tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Leviroz 750mg tablets. Dosage modification of Leviroz 750mg tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
Leviroz 750mg tablets are likely safe for individuals with liver conditions. Available evidence indicates dose modification may be unnecessary in such cases. Physician consultation is recommended. Nevertheless, a reduced dosage might be appropriate for patients experiencing severe hepatic impairment.
What if you forget to take Leviroz 750mg Tablet :
Should you forget a Leviroz 750mg Tablet dose, take it immediately. But if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Leviroz 750mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Pyrrolidinone-Acetamide derivative |
| Developing Habits | No. |
| Treatment Category | Neuroscience Central Nervous System |
| Actions | AED: A protein ligand within synaptic vesicle 2 |
